✨ Health Notices




920 NEW ZEALAND GAZETTE, No. 32 25 MARCH 2010

Health

Misuse of Drugs (Industrial Hemp) Regulations 2006

Approved Cultivar of Industrial Hemp

Acting pursuant to Regulation 5(1) of the Misuse of Drugs (Industrial Hemp) Regulations 2006, I, Sue Scott, Team Leader, Medicines Control, Regulation and Governance, Ministry of Health, acting under delegation from the Director-General of Health, hereby approve the cultivar of industrial hemp described below, for the purposes of that Regulation:

FEDORA 17

Dated at Wellington this 18th day of March 2010.

SUE SCOTT, Team Leader, Medicines Control, Regulation and Governance, Ministry of Health.

go2217

Medicines Act 1981

Consent to the Distribution of New Related Products

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new related products set out in the Schedule hereto:

Schedule

Product: 3M ESPE Clinpro Tooth Creme
Active Ingredient: Sodium fluoride 0.21%w/w
Dosage Form: Toothpaste
New Zealand Sponsor: 3M New Zealand Limited
Manufacturer: Sheffield Laboratories, New London, United States of America

Product: Mouthfresh Fresh Mint Gel
Active Ingredient: Sodium monofluorophosphate 0.76%w/w
Dosage Form: Toothpaste
New Zealand Sponsor: Global Products Limited
Manufacturer: Bhavi Tubes and Containers Pvt Limited, Gujarat, India

Product: Mouthfresh Ice Mint Gel
Active Ingredient: Sodium monofluorophosphate 0.76%w/w
Dosage Form: Toothpaste
New Zealand Sponsor: Global Products Limited
Manufacturer: Bhavi Tubes and Containers Pvt Limited, Gujarat, India

Product: Oral-B Tooth and Gum Care Alcohol-Free Mouth Rinse
Active Ingredients:

  • Cetylpyridinium chloride monohydrate 0.05%w/w
  • Sodium fluoride 0.05%w/w
    Dosage Form: Mouthwash
    New Zealand Sponsor: Procter & Gamble Distributing New Zealand Limited
    Manufacturer: Laboratorios Rety de Colombia S.A., Barranquilla, Colombia

Dated this 18th day of March 2010.

MARK RICHARDS, Acting Deputy Director-General, Regulation and Governance Directorate, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).

go2166

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product: Hycamtin
Active Ingredient: Topotecan hydrochloride 0.27mg equivalent to 0.25mg topotecan
Dosage Form: Capsule
New Zealand Sponsor: GlaxoSmithKline (NZ) Limited
Manufacturer: GlaxoSmithKline Manufacturing SpA, Parma, Italy



Next Page →



Online Sources for this page:

Gazette.govt.nz PDF NZ Gazette 2010, No 32





✨ LLM interpretation of page content

πŸ₯ Approval of Industrial Hemp Cultivar

πŸ₯ Health & Social Welfare
18 March 2010
Industrial Hemp, Cultivar, Approval, FEDORA 17
  • Sue Scott, Team Leader, Medicines Control, Regulation and Governance, Ministry of Health

πŸ₯ Consent to Distribution of New Related Products

πŸ₯ Health & Social Welfare
18 March 2010
Medicines, Distribution, Toothpaste, Mouthwash
  • Mark Richards, Acting Deputy Director-General, Regulation and Governance Directorate, Ministry of Health

πŸ₯ Consent to Distribution of New Medicines

πŸ₯ Health & Social Welfare
18 March 2010
Medicines, Distribution, Hycamtin, Topotecan
  • Mark Richards, Acting Deputy Director-General, Regulation and Governance Directorate, Ministry of Health